ABSTRACT

mRNA Technologies: A Primer [May 24, 2022]   [open pdf - 1MB]

From the Introduction: "The unprecedented development speed of the Pfizer/BioNTech and Moderna Coronavirus Disease 2019 (COVID-19 [coronavirus disease 2019]) vaccines highlight just one application of emerging technologies based on messenger RNA [Ribonucleic acid] (mRNA [messenger Ribonucleic acid]), which have many promising uses and benefits. In addition to enabling rapid vaccine development for emerging infectious diseases, these technologies may soon have wider application in preventing and treating other diseases. This report discusses what mRNA is and why it has so many potential uses; how the federal government and private companies developed these technologies; federal and other investments in research and development (R&D) related to these technologies; future potential uses; and congressional considerations raised by these technologies."

Report Number:
CRS Report for Congress, R47112
Author:
Publisher:
Date:
2022-05-24
Copyright:
Public Domain
Retrieved From:
Congressional Research Service: https://crsreports.congress.gov/
Format:
pdf
Media Type:
application/pdf
URL:
Help with citations